Related Experiment Video
Updated: Aug 12, 2026
10:29
Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
CD4- and CD8-to-Total Lymphocyte Ratios to Guide Rabbit Anti-Thymocyte Globulin Induction in Kidney Transplant
I-Ru Chen1, Ping-Chin Lai1, Chiu-Ching Huang1
1Division of Nephrology and the Kidney Institute, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Nephrology (Carlton, Vic.)
|August 11, 2026
Summary
Individualized rabbit anti-thymocyte globulin (rATG) dosing guided by lymphocyte ratios is feasible, achieving immune targets with low exposure. This strategy shows promise for kidney transplant recipients, warranting further study.
Area of Science:
- Nephrology
- Immunology
- Transplantation Medicine
Background:
- Rabbit anti-thymocyte globulin (rATG) is a standard induction immunosuppressant in kidney transplantation.
- Current weight-based dosing may not align with individual immune responses.
- Optimizing rATG dosing is crucial for balancing efficacy and safety.
Purpose of the Study:
- To evaluate an individualized rATG dosing strategy based on CD4 and CD8 T-lymphocyte ratios.
- To assess the feasibility and 1-year outcomes of this targeted dosing approach.
Main Methods:
- A single-center retrospective cohort study of 76 kidney transplant recipients.
- rATG dosing was guided by flow cytometry to achieve CD4/TLC and CD8/TLC ratios <10%.
- Outcomes included rATG exposure, rejection rates, graft function, infections, and mortality.
Main Results:
- 50% of recipients achieved target ratios with a single dose.
- Low rates of biopsy-proven acute rejection (1.3%) and no graft loss at 1 year.
- Hospitalization-requiring infections occurred in 22 episodes; 5.3% mortality.
Conclusions:
- Individualized rATG dosing guided by lymphocyte ratios is feasible and effective.
- This approach led to reduced rATG exposure and favorable 1-year outcomes.
- Prospective studies are needed to confirm clinical utility and comparative effectiveness.
